儿童甲状腺激素抵抗综合征伴发育障碍2例

廖林英, 李杏芳, 张星星

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (1) : 115-119.

PDF(932 KB)
HTML
PDF(932 KB)
HTML
中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (1) : 115-119. DOI: 10.7499/j.issn.1008-8830.2504083
病例报告

儿童甲状腺激素抵抗综合征伴发育障碍2例

作者信息 +

Resistance to thyroid hormone syndrome with developmental disorders in two children

Author information +
文章历史 +

摘要

患儿1,男,4岁,因语言发育迟缓就诊,甲状腺功能显示游离三碘甲状腺原氨酸、游离甲状腺素持续升高,促甲状腺激素正常或升高,基因检测发现THRB基因c.1373T>C(p.Val458Ala)新生杂合突变,诊断为甲状腺激素抵抗综合征(resistance to thyroid hormone syndrome, RTH),未予特殊药物治疗,定期随访观察。患儿2,男,2岁,新生儿筛查发现促甲状腺激素升高,甲状腺功能异常持续1年10个月,伴生长迟缓及心动过速,基因检测提示THRB基因c.959G>A(p.Arg320His)新生杂合突变,诊断为垂体型RTH,予普萘洛尔控制心率。RTH临床表现异质性大,易误诊漏诊。对于不明原因甲状腺功能异常伴发育障碍的患儿,需警惕本病可能,早期THRB基因检测有助于精准诊断与治疗决策。

Abstract

Patient 1, a 4-year-old boy, presented with delayed language development. Persistently elevated free triiodothyronine (FT3) and free thyroxine (FT4) were found, with normal or elevated thyroid-stimulating hormone (TSH). A de novo heterozygous mutation in the THRB gene (c.1373T>C, p.Val458Ala) was identified, and resistance to thyroid hormone syndrome (RTH) was diagnosed. No specific medication was administered, and regular follow-up was arranged. Patient 2, a 2-year-old boy, had elevated TSH detected on neonatal screening. Thyroid dysfunction persisted for 1 year and 10 months and was accompanied by growth delay and tachycardia. Genetic testing revealed a de novo heterozygous mutation in the THRB gene (c.959G>A, p.Arg320His), and pituitary-type RTH was diagnosed. Propranolol was administered for heart rate control. RTH shows marked clinical heterogeneity and is prone to misdiagnosis or missed diagnosis. For children with unexplained thyroid dysfunction and developmental disorders, early THRB gene testing helps achieve precise diagnosis and guide treatment decisions.

关键词

甲状腺激素抵抗综合征 / 甲状腺激素β受体 / 发育障碍 / 基因检测 / 儿童

Key words

Resistance to thyroid hormone syndrome / Thyroid hormone receptor beta / Developmental disorder / Genetic testing / Child

引用本文

导出引用
廖林英, 李杏芳, 张星星. 儿童甲状腺激素抵抗综合征伴发育障碍2例[J]. 中国当代儿科杂志. 2026, 28(1): 115-119 https://doi.org/10.7499/j.issn.1008-8830.2504083
Lin-Ying LIAO, Xing-Fang LI, Xing-Xing ZHANG. Resistance to thyroid hormone syndrome with developmental disorders in two children[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(1): 115-119 https://doi.org/10.7499/j.issn.1008-8830.2504083

参考文献

[1]
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30 .
[2]
Weiss RE, Hayashi Y, Nagaya T, et al. Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor[J]. J Clin Endocrinol Metab, 1996, 81(12): 4196-4203. DOI: 10.1210/jcem.81.12.8954015 .
[3]
Ong JC, Omar WMH W, Tuan Ismail TS, et al. R243W mutation in thyroid hormone resistance syndrome beta: a case report[J]. J ASEAN Fed Endocr Soc, 2024, 39(2): 81-85. PMCID: PMC11604371. DOI: 10.15605/jafes.039.02.04 .
[4]
Xiao X, Lv C, Zhu T, et al. Thyroid hormone resistance and the value of genetics: three case reports[J]. Medicine (Baltimore), 2019, 98(9): e14675. PMCID: PMC6831408. DOI: 10.1097/MD.0000000000014675 .
[5]
Mondal S, Raja K, Schweizer U, et al. Chemistry and biology in the biosynthesis and action of thyroid hormones[J]. Angew Chem Int Ed Engl, 2016, 55(27): 7606-7630. DOI: 10.1002/anie.201601116 .
[6]
Parrilla R, Mixson AJ, McPherson JA, et al. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain[J]. J Clin Invest, 1991, 88(6): 2123-2130. PMCID: PMC295818. DOI: 10.1172/JCI115542 .
[7]
Ortiga-Carvalho TM, Sidhaye AR, Wondisford FE. Thyroid hormone receptors and resistance to thyroid hormone disorders[J]. Nat Rev Endocrinol, 2014, 10(10): 582-591. PMCID: PMC4578869. DOI: 10.1038/nrendo.2014.143 .
[8]
Adams M, Matthews C, Collingwood TN, et al. Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene[J]. J Clin Invest, 1994, 94(2): 506-515. PMCID: PMC296123. DOI: 10.1172/JCI117362 .
[9]
Jackowski T, Petriczko E, Horodnicka-Józwa A, et al. Thyroid hormone resistance syndrome: own experiences[J]. Pediatr Endocrinol Diabetes Metab, 2017, 23(4): 209-214. DOI: 10.18544/PEDM-23.04.0095 .
[10]
Weiss RE, Tunca H, Gerstein HC, et al. A new mutation in the thyroid hormone receptor (TR) beta gene (V458A) in a family with resistance to thyroid hormone (RTH)[J]. Thyroid, 1996, 6(4): 311-312. DOI: 10.1089/thy.1996.6.311 .
[11]
Han R, Ye L, Jiang X, et al. Characteristics of patients with late manifestation of resistance thyroid hormone syndrome: a single-center experience[J]. Endocrine, 2015, 50(3): 689-697. DOI: 10.1007/s12020-015-0622-x .
[12]
Narumi S, Cho H, Tamada I, et al. One novel and two recurrent THRB mutations associated with resistance to thyroid hormone: structure-based computational mutation prediction[J]. Clin Pediatr Endocrinol, 2010, 19(4): 91-99. PMCID: PMC3687625. DOI: 10.1297/cpe.19.91 .
[13]
Fang Y, Liu T, Hou H, et al. Resistance to thyroid hormone beta coexisting with papillary thyroid carcinoma: two case reports of a thyroid hormone receptor beta gene mutation and a literature review[J]. Front Genet, 2022, 13: 1014323. PMCID: PMC9751197. DOI: 10.3389/fgene.2022.1014323 .
[14]
Weiss RE, Weinberg M, Refetoff S. Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families[J]. J Clin Invest, 1993, 91(6): 2408-2415. PMCID: PMC443299. DOI: 10.1172/JCI116474 .
[15]
Grasberger H, Ringkananont U, Croxson M, et al. Resistance to thyroid hormone in a patient with thyroid dysgenesis[J]. Thyroid, 2005, 15(7): 730-733. DOI: 10.1089/thy.2005.15.730 .
[16]
郭曼丽, 仇亚丽, 李京, 等. THRβ基因c.728G>A突变致甲状腺激素抵抗综合征家系6年随访[J]. 温州医科大学学报, 2023, 53(2): 146-151. DOI: 10.3969/j.issn.2095-9400.2023.02.011 .
[17]
楚闪闪, 王旭, 周巧利, 等. 新生儿呕吐: 一种新的甲状腺激素抵抗综合征表型[J]. 南京医科大学学报(自然科学版), 2022, 42(10): 1495-1498. DOI: 10.7655/NYDXBNS20221024 .
[18]
Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone[J]. Endocr Rev, 1993, 14(3): 348-399. DOI: 10.1210/edrv-14-3-348 .
[19]
Weiss RE, Refetoff S. Treatment of resistance to thyroid hormone: primum non nocere[J]. J Clin Endocrinol Metab, 1999, 84(2): 401-404. DOI: 10.1210/jcem.84.2.5534 .
[20]
Anyfantakis A, Anyfantakis D, Vourliotaki I. Syndrome of reduced sensitivity to thyroid hormones: two case reports and a literature review[J]. Case Rep Endocrinol, 2016, 2016: 7546453. PMCID: PMC5059527. DOI: 10.1155/2016/7546453 .
[21]
Beck-Peccoz P, Piscitelli G, Cattaneo MG, et al. Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC)[J]. J Endocrinol Invest, 1983, 6(3): 217-223. DOI: 10.1007/BF03350611 .
[22]
Groeneweg S, Peeters RP, Visser TJ, et al. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes[J]. Mol Cell Endocrinol, 2017, 458: 82-90. DOI: 10.1016/j.mce.2017.02.029 .
[23]
Williams G, Kraenzlin M, Sandler L, et al. Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995)[J]. Acta Endocrinol (Copenh), 1986, 113(1): 42-46.
[24]
Beck-Peccoz P, Mariotti S, Guillausseau PJ, et al. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995[J]. J Clin Endocrinol Metab, 1989, 68(1): 208-214. DOI: 10.1210/jcem-68-1-208 .

脚注

所有作者均声明无利益冲突。


版权

版权所有 © 2023中国当代儿科杂志
PDF(932 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/